Navigation Links
Intersurgical, ERDRICH Umformtechnik, Bridgestone Collaborates with Changzhou National Hi-Tech District
Date:9/10/2013

CHANGZHOU, China, Sept. 10, 2013 /PRNewswire/ -- UK-based medical devices manufacturer Intersurgical, Germany's Erdrich Umformtechnik and Japan-based Bridgestone have partnered with Changzhou National Hi-Tech District (CND) in Jiangsu, China, demonstrating their confidence in the Chinese market despite the challenging global economy.

Intersurgical Medical Device (Changzhou), a 9-million-British pound (approx. US$14.1 million) project set up in CND's Bio-Pharmaceutical Industrial Park, plans to begin construction in November 2013. The new project is Intersurgical's first wholly-owned production base in China and will produce devices for airway management, anesthesia, critical care and oxygen and aerosol therapy. Founded in 1982, Intersurgical is a leader in the anesthesia and respiratory supplies sector with subsidiaries in 13 countries. Intersurgical is the first company with a line of non-PVC anesthesia and respiratory products worldwide, benefiting the environment and people's health.

On August 27, Bridgestone further invested US$50 million in building a bicycle plant at CND. The facility is expected to have an annual capacity of 1 million bicycles, 100,000 electric bicycles, 500,000 bicycle parts and 2 million stainless bicycle rims, capable of generating sales of 1.15 billion yuan (approx. US$188 million) yearly. The firm will employ 1,200 workers. Bridgestone is the world's largest tire and rubber product manufacturer and a Fortune Global 500 company, with 2012 sales reaching US$35 billion. The company has established three wholly-owned plants at CND, which are involved, respectively, in bicycles, fluid technology and auto parts.

The groundbreaking ceremony for the US$20 million Erdrich Umformtechnik Metal Forming Technology (Changzhou) Company was held at CND on September 5. The company specializes in key automotive parts used in steering and suspension systems including steering linkages and cross arms for high-end German carmakers operating in China via in-house developed high precision molding. The new venture's customers include complete carmakers like BMW, Benz and VW as well as first-tier suppliers like Bosch. Erdrich CEO Georg Erdrich and his son said that as the Changzhou municipal government provided accurate and timely answers and solutions to a variety of issues, strengthening a sense of security and trust, they chose CND without hesitation over seven other Chinese cities.

CONTACT
Wang Zhongliang
Changzhou National Hi-Tech District (Xinbei District), Jiangsu province
Tel: 86-(0)519-8512 7305
Fax: 86-(0)519-8511 5905
E-mail: w_zongliang@sohu.com


'/>"/>
SOURCE Changzhou National Hi-Tech District
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Collaborates with One Mind for Research to Advance Traumatic Brain Injury Knowledge
2. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
3. Academy of Managed Care Pharmacy Collaborates with National Association of Specialty Pharmacy to Host Inaugural AMCP/NASP Specialty Pharmacy Conference
4. BodyMedia Collaborates on Federal Health Research Study
5. Nonin Medical, Inc. Collaborates with Qualcomm Life to Provide Pulse Oximetry for the 2net Platform for Wireless Health Solutions
6. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
7. Life Technologies Collaborates with USDA to Develop Same-Day, Multi-Strain E. coli Detection System
8. DICOM Grid Collaborates with Mayo Clinic on Mobile Image Viewing Technology
9. GNS Healthcare Collaborates With A Leading CRO To Enable More Efficient And Cost-Effective Drug Development
10. DMH International Announces Agreement with MyDICOM and ChangZhou Wealth Information & Technology Co. Ltd
11. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):